Oglemilast

DB12375InvestigationalSmall molecule

Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

Chemical structure of Oglemilast
Mechanism
Curator reviewed
Formula / weight
C20H13Cl2F2N3O5S · 516.3 g/mol (avg)
Code names
GRC 3845

Resolves to

Compound
UNII67GXQ6WCC6CAS778576-62-8PubChem11387409
Structure
InChIKeyOKFDRAHPFKMAJH-UHFFFAOYSA-NSMILESCS(=O)(=O)NC1=CC2=C(OC3=C2C(=CC=C3OC(F)F)C(=O)NC2=C(Cl)C=NC=C2Cl)C=C1
Targets
Q08499PDE4DQ07343PDE4BP27815PDE4A

What you can answer from here — as of August 30, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oglemilast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In